Delivery Order SPE2DB20D9331-SPE2DB21FL1Q6

Award Date 8/5/21
Potential Completion Date 8/26/21
Potential Value $124K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,574,962 units of the oncology drug ONCASPAR in 5 mL vials. The contract is not associated with a set-aside designation. It is a delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,440.56 firm fixed-price delivery order is for the supply of ONCASPAR 3,750 UNIT/5 ML VIAL 5ML, a pharmaceutical product, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,565,482,195 units of the medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $82,930.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,565,043 units of the oncology drug ONCASPAR in 5 ml vials. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order (SPE2DB22FL1E3) with a ceiling value of $86,440.56 and a completion date of July 28, 2022. The contract is for the supply of 4,557,808 units of the drug ONCASPAR, a 3,750 unit/5 ml vial, to support the recurring medical supply needs of military health...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,804,056 units of the oncology medication ONCASPAR (pegaspargase) in 5 mL vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, which allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $49,531.40 contract is for the delivery of 3,750 units of the oncology medication ONCASPAR in 5 mL vials. This order is placed under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery orders for a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award of $49,531.40 is for the delivery of 3,750 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,531.40, is a firm fixed-price delivery order for 4,560,593,542 units of the prescription drug ONCASPAR (3,750 units/5 ml vial, 5 ml). The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery...
This federal contract award, valued at $86,440.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,557,549,804 units of the oncology medication ONCASPAR in 5 ML vials. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB21FL1Q6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $124,396.08 firm fixed-price delivery order is for the supply of 4,554,408,511 units of the oncology drug ONCASPAR (3,750 unit/5 mL vial, 5 mL) to support the recurring medical supply needs of military health facilities.

This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of Department of Defense (DoD) healthcare facilities worldwide. This contract does not have a set-aside designation.

Generated 1/9/25, 9:20 AM